Search - tctmd.com

Displaying 601 - 620 of 676

Sort: Relevancy | Date

Presentation TCT 2014

TCT 403: Peripheral Endothelial Function and Sympathetic Influence on Dermal Microcirculation Correlate with Long-term Blood Pressure Response in Renal Denervation Patients

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Ulrich Hink

September 13, 2014

Presentation TCT 2014

Preclinical Insights Into the Optimal Ablation Location for Renal Denervation Procedures

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Robert J. Melder

September 13, 2014

Presentation TCT 2014

TCT 402: Renal Norepinephrine Reduction Following Radiofrequency Renal Denervation Correlates with Extent of Nerve Ablation: Roles of Ablation Areas, Anatomy, and Number of Treatments

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Rami Tzafriri

September 13, 2014

Presentation TCT 2014

There Is Hope for Producing Preclinical Models for Successful Device Development

Presenter: Gregory J. Wilson

September 13, 2014

Presentation TCT 2014

Lack of Preclinical Understanding Underlies the Negative Randomized Trial Results!

Presenter: Robert S. Schwartz

September 13, 2014

Presentation TCT 2014

Renal Nerve Microanatomy - The Foundation for RDN Technologies

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Michael Joner

September 13, 2014

$SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups$

Presentation TCT 2014

SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups

Presenter: Patrick W. Serruys, Deepak L. Bhatt

September 13, 2014

News Conference News TCT 2014

SYMPLICITY HTN-3: Crossover Patients Strengthen the Case for Renal Denervation

September 13, 2014

News Conference News TCT 2014

Experts Debate Future of Renal Denervation Therapy

September 13, 2014

News Conference News TCT 2013

Pulmonary Artery Denervation Procedure May Improve Hemodynamic Outcomes in PAH

November 05, 2013

Presentation TCT 2013

Noninvasive Evaluation of Resistant Hypertension: Two Case Examples

Presenter: Michael Jaff

October 31, 2013

Presentation TCT 2013

Noninvasive Evaluation and Treatment of Resistant Hypertension

Presenter: C. Venkata S. Ram

October 31, 2013

News Conference News TCT 2013

FREEDOM: Insulin Status Affects Revascularization Outcomes in Diabetic Patients

October 31, 2013

Presentation TCT 2013

Flash Lecture #3: Renal Denervation: Beyond Hypertension!

Presenter: Fabio Brito Jr.

October 30, 2013

Presentation TCT 2013

Renal Denervation Beyond Hypertension: Status Update and Study Pathways for New Clinical Indications

Presenter: Felix Mahfoud

October 30, 2013

Presentation TCT 2013

Expanding Clinical Indications: Moderate Hypertension and Replacing (vs. Supplementing) Medical Pharmacotherapy

Presenter: Krishna Rocha-Singh

October 30, 2013

News Conference News TCT 2013

TCT Leadership Outlines the State of Intervention

October 30, 2013

News Conference News TCT 2013

Renal Denervation Systems Show Persistent Reductions in BP

October 30, 2013

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

Presentation TCT 2013

Pulmonary artery denervation to treat pulmonary arterial hypertension: a single-center, prospective, first-in-man PADN-1 study

Presenter: Shao-?Liang Chen

October 29, 2013

Advertisement

TCT 403: Peripheral Endothelial Function and Sympathetic Influence on Dermal Microcirculation Correlate with Long-term Blood Pressure Response in Renal Denervation Patients

Preclinical Insights Into the Optimal Ablation Location for Renal Denervation Procedures

TCT 402: Renal Norepinephrine Reduction Following Radiofrequency Renal Denervation Correlates with Extent of Nerve Ablation: Roles of Ablation Areas, Anatomy, and Number of Treatments

There Is Hope for Producing Preclinical Models for Successful Device Development

Lack of Preclinical Understanding Underlies the Negative Randomized Trial Results!

Renal Nerve Microanatomy - The Foundation for RDN Technologies

SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups

SYMPLICITY HTN-3: Crossover Patients Strengthen the Case for Renal Denervation

Experts Debate Future of Renal Denervation Therapy

Pulmonary Artery Denervation Procedure May Improve Hemodynamic Outcomes in PAH

Noninvasive Evaluation of Resistant Hypertension: Two Case Examples

Noninvasive Evaluation and Treatment of Resistant Hypertension

FREEDOM: Insulin Status Affects Revascularization Outcomes in Diabetic Patients

Flash Lecture #3: Renal Denervation: Beyond Hypertension!

Renal Denervation Beyond Hypertension: Status Update and Study Pathways for New Clinical Indications

Expanding Clinical Indications: Moderate Hypertension and Replacing (vs. Supplementing) Medical Pharmacotherapy

TCT Leadership Outlines the State of Intervention

Renal Denervation Systems Show Persistent Reductions in BP

Innovation in Intervention: Perspectives from Industry

Pulmonary artery denervation to treat pulmonary arterial hypertension: a single-center, prospective, first-in-man PADN-1 study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content